Mallinckrodt acquires Stratatech Corporation

Mallinckrodt has bought Stratatech Corporation, a medicine company which specialises in the development of human skin substitute products. Currently awaiting approval, Stratatech’s products could revolutionise the treatment patients receive for second- and third-degree burns. Mallinckrodt develops, manufactures, markets and distributes speciality pharmaceutical and biopharmaceutical products and therapies, as well as nuclear imaging products.

Leave a Reply

Your email address will not be published. Required fields are marked *